Literature DB >> 25017069

Neurexin dysfunction in adult neurons results in autistic-like behavior in mice.

Luis G Rabaneda1, Estefanía Robles-Lanuza1, José Luis Nieto-González2, Francisco G Scholl3.   

Abstract

Autism spectrum disorders (ASDs) comprise a group of clinical phenotypes characterized by repetitive behavior and social and communication deficits. Autism is generally viewed as a neurodevelopmental disorder where insults during embryonic or early postnatal periods result in aberrant wiring and function of neuronal circuits. Neurexins are synaptic proteins associated with autism. Here, we generated transgenic βNrx1ΔC mice in which neurexin function is selectively impaired during late postnatal stages. Whole-cell recordings in cortical neurons show an impairment of glutamatergic synaptic transmission in the βNrx1ΔC mice. Importantly, mutant mice exhibit autism-related symptoms, such as increased self-grooming, deficits in social interactions, and altered interaction for nonsocial olfactory cues. The autistic-like phenotype of βNrx1ΔC mice can be reversed after removing the mutant protein in aged animals. The defects resulting from disruption of neurexin function after the completion of embryonic and early postnatal development suggest that functional impairment of mature circuits can trigger autism-related phenotypes.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25017069     DOI: 10.1016/j.celrep.2014.06.022

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  25 in total

Review 1.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

2.  Type I bHLH Proteins Daughterless and Tcf4 Restrict Neurite Branching and Synapse Formation by Repressing Neurexin in Postmitotic Neurons.

Authors:  Mitchell D'Rozario; Ting Zhang; Edward A Waddell; Yonggang Zhang; Cem Sahin; Michal Sharoni; Tina Hu; Mohammad Nayal; Kaveesh Kutty; Faith Liebl; Wenhui Hu; Daniel R Marenda
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

3.  Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic Vesicle Release.

Authors:  Emilia Servián-Morilla; Estefanía Robles-Lanuza; Ana C Sánchez-Hidalgo; Rafael J Camacho-Garcia; Juan A Paez-Gomez; Fabiola Mavillard; Carlos A Saura; Amalia Martinez-Mir; Francisco G Scholl
Journal:  J Neurosci       Date:  2017-12-11       Impact factor: 6.167

4.  The utility of rodent models of autism spectrum disorders.

Authors:  Maria T Lázaro; Peyman Golshani
Journal:  Curr Opin Neurol       Date:  2015-04       Impact factor: 5.710

Review 5.  Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.

Authors:  S W Hulbert; Y-H Jiang
Journal:  Neuroscience       Date:  2015-12-28       Impact factor: 3.590

Review 6.  Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.

Authors:  Erin K Flaherty; Kristen J Brennand
Journal:  Brain Res       Date:  2015-11-12       Impact factor: 3.252

Review 7.  Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders.

Authors:  Zhonghua Hu; Xiao Xiao; Zhuohua Zhang; Ming Li
Journal:  Mol Psychiatry       Date:  2019-05-28       Impact factor: 15.992

Review 8.  Neurexins: molecular codes for shaping neuronal synapses.

Authors:  Andrea M Gomez; Lisa Traunmüller; Peter Scheiffele
Journal:  Nat Rev Neurosci       Date:  2021-01-08       Impact factor: 34.870

9.  Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice.

Authors:  Qian Wang; Ying Kong; Ding-Yu Wu; Ji-Hong Liu; Wei Jie; Qiang-Long You; Lang Huang; Jian Hu; Huai-De Chu; Feng Gao; Neng-Yuan Hu; Zhou-Cai Luo; Xiao-Wen Li; Shu-Ji Li; Zhao-Fa Wu; Yu-Long Li; Jian-Ming Yang; Tian-Ming Gao
Journal:  Nat Commun       Date:  2021-05-31       Impact factor: 14.919

Review 10.  Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions.

Authors:  Bryan Mowry; Jean Giacomotto; Alisha Tromp
Journal:  Mol Psychiatry       Date:  2020-11-15       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.